Halozyme Therapeutics (HALO) PT Raised to $22 at JPMorgan
Tweet
Share
E-mailGet Alerts HALO Hot Sheet
Price: $79.45 +3.17%
Rating Summary:
14 Buy, 6 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Rating Summary:
14 Buy, 6 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Join SI Premium – FREE
JPMorgan raised its price target on Halozyme Therapeutics (NASDAQ: HALO) to $22.00 (from $19.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Starts Kanzhun Ltd (2076:HK) at Overweight
- Tech Mahindra Ltd. (TECHM:IN) PT Lowered to INR1,775 at BNP Paribas Exane
- LTM Ltd (LTM:IN) PT Lowered to INR3,945 at BNP Paribas Exane
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
